LPCN
Lipocine Inc
NASDAQ · Pharmaceuticals
$8.49
+0.77 (+9.97%)
Open$7.84
Previous Close$7.72
Day High$8.91
Day Low$7.84
52W High$19.74
52W Low$10.79
Volume—
Avg Volume742.3K
Market Cap47.14M
P/E Ratio13.81
EPS$1.08
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+128.6% upside
Current
$8.49
$8.49
Target
$19.41
$19.41
$13.09
$19.41 avg
$19.72
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 21.89M | 22.16M | 17.20M |
| Net Income | 3.29M | 3.56M | 2.74M |
| Profit Margin | 15.1% | 16.1% | 15.9% |
| EBITDA | 4.47M | 4.85M | 3.77M |
| Free Cash Flow | 2.95M | 3.49M | 2.02M |
| Rev Growth | -6.8% | +9.7% | +22.0% |
| Debt/Equity | 0.14 | 0.13 | 0.14 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |